Return to Home

Vicor Corporation

VICR

Find Out if You Qualify for a Financial Reward by filling out the form below.

Vicor Corporation Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On October 24, 2023, Vicor announced inline 3Q23 results and 4Q23 guidance but backlog continued to decrease and “bookings remained weak.” Analysts commented that management’s reluctance to discuss AI platforms announced in the previous quarter “shows a shrink in opportunity.”

Following this news, Vicor’s stock price fell by $14.14 per share, or approximately 26% to close at $39.05 per share.

Find More Cases

Ticker Symbol Company Name Join Deadline
IOVA Iovance Biotherapeutics, Inc. July 14, 2025 Join
OGN Organon & Co. July 22, 2025 Join
VSTS Vestis Corporation August 08, 2025 Join
RCKT Rocket Pharmaceuticals, Inc. August 11, 2025 Join
CNC Centene Corporation September 08, 2025 Join